Intravoxel incoherent motion combined with conventional MRI for the differentiation of benign, intermediate, and malignant fibrous soft-tissue tumors - Report - MDSpire
Advertisement
Intravoxel incoherent motion combined with conventional MRI for the differentiation of benign, intermediate, and malignant fibrous soft-tissue tumors
Clinical Report: Utilizing Intravoxel Incoherent Motion alongside Standard MRI
Overview
This study evaluates the effectiveness of intravoxel incoherent motion (IVIM) and conventional MRI in differentiating benign, intermediate, and malignant fibrous soft-tissue tumors (STTs).
Background
Fibroblastic/myofibroblastic tumors represent a common category of soft-tissue tumors, with varying degrees of malignancy. Accurate differentiation between benign, intermediate, and malignant tumors is crucial for determining appropriate treatment strategies. The overlapping MRI features of these tumors complicate diagnosis, highlighting the need for advanced imaging techniques like IVIM.
Data Highlights
Parameter
Benign
Intermediate
Malignant
Standard-ADCmean
Higher
Lower
Lowest
Dmean
Higher
Lower
Lowest
fmean
Lower
Lower
Higher
Key Findings
Malignant tumors exhibited higher heterogeneity on T2WI and contrast enhancement T1WI compared to benign and intermediate tumors.
Necrosis was more prevalent in malignant tumors than in benign and intermediate tumors.
Intermediate and malignant tumors showed tail-like patterns and invasiveness more frequently than benign tumors.
Standard-ADCmean had the highest AUC (0.894) for differentiating intermediate from benign STTs.
Dmean demonstrated the highest AUC (0.961) for distinguishing malignancies from benign STTs.
The combination of conventional MRI signs and IVIM parameters yielded the highest AUC of 0.971 for differentiating benign from non-benign STTs.
Clinical Implications
The integration of IVIM parameters with conventional MRI can enhance the differentiation of fibrous STTs.
Conclusion
IVIM diffusion parameters provide valuable insights for differentiating between benign, intermediate, and malignant fibrous STTs, complementing conventional MRI findings.